Procter & Gamble Health Ltd - 500126 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1120 Name of the Signatory :- Preeti Bishnoi Designation :- Company Secretary and Compliance Officer Procter & Gamble Health Ltd - 500126 - Related Party Transactions For Six Months Ended June 30, 2020
We are enclosing herewith the Related Party Transactions for six months ended June 30, 2020. Kindly take the same on record and oblige. Procter & Gamble Health Ltd - 500126 - Closure of Trading Window
We would like to inform you that the Trading Window of the Company shall remain closed for Directors and designated employees from October 1, 2020 until 48 hours from the publication of the unaudited financial results for quarter ended September 30, 2020. Kindly take the same on record. Procter & Gamble Health Ltd - 500126 - Fixes Book Closure for Dividend & AGM
Procter & Gamble Health Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from November 20, 2020 to November 26, 2020 (both days inclusive) for the purpose of Payment of Dividend & 53rd Annual General Meeting (AGM) of the Company to be held on November 26, 2020. Procter & Gamble Health Ltd - 500126 - 53Rd Annual General Meeting
We would like to inform you that the 53rd Annual General Meeting of the Company is scheduled to be held on Thursday, November 26, 2020 through Video Conferencing/Other Audio Visual means, in compliance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India due to the current COVID-19 pandemic. We would further like to inform you that the Register of Members and Share Transfer books shall remain closed from Friday, November 20, 2020 to Thursday, November 26, 2020 (both days inclusive) for the purposes of Annual General Meeting and payment of dividend for the year ended June 30, 2020, if approved by members at the 53rd Annual General Meeting. The notice convening the 53rd Annual General Meeting of the Company will be provided in due course of time. Kindly take the same on record. Procter & Gamble Health Ltd - 500126 - Corporate Action-Board approves Dividend
We are pleased to inform you that the Board of Directors of the Company at its meeting held today, inter alia, have recommended a final dividend of Rs. 230 per equity share, for the eighteen month financial year ended June 30, 2020, which includes a one-time special dividend of Rs. 188 per equity share. The dividend shall be paid between November 30, 2020 to December 18, 2020, on approval of the Members at the 53rd Annual General Meeting scheduled on November 26, 2020. Procter & Gamble Health Ltd - 500126 - Audited Financial Results For 18 Months Financial Year Ended June 30, 2020
We are pleased to inform you that at the meeting of the Board of Directors of the Company held today, the Audited Financial Results for the eighteen month period Year ended June 30, 2020 were approved. We are enclosing herewith the following: a. Audited Financial Results for the eighteen month period ended June 30, 2020, as per format prescribed under Regulation 33 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015; b. Auditor's Report, in respect of the aforementioned Financial Results, as furnished by the Statutory Auditors of the Company; c. Press Release; and d. A declaration with respect to Audit Report with unmodified opinion to the aforementioned Audited Financial Results Procter & Gamble Health Ltd - 500126 - Audited Financial Results For 18 Months Financial Year Ended June 30, 2020
We are pleased to inform you that at the meeting of the Board of Directors of the Company held today, the Audited Financial Results for the eighteen month period Year ended June 30, 2020 were approved. We are enclosing herewith the following: a. Audited Financial Results for the eighteen month period ended June 30, 2020, as per format prescribed under Regulation 33 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015; b. Auditor's Report, in respect of the aforementioned Financial Results, as furnished by the Statutory Auditors of the Company; c. Press Release; and d. A declaration with respect to Audit Report with unmodified opinion to the aforementioned Audited Financial Results Procter & Gamble Health Ltd - 500126 - Outcome Of The Board Meeting Held On September 15, 2020
Please see attached the outcome of the Board meeting held on September 15, 2020.